Small biotechs versus large pharma: Who drives first-in-class innovation in oncology?

待确认 10 由王睿童发布于 2026/3/14 21:47:57

DOI:10.1016/j.drudis.2022.103456
作者：Kate H. Kennedy ,?Krisstel Gomez,?Natalie J. Thovmasian,?Dennis C. Chang
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：There is a narrative that large pharma relies on biotech and academia for drug innovation. We tested this thesis by identifying the originators of all 50 first-in-class (FIC) oncology drugs

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

21小时前

yduan

780f6f081fac11f198dc34735aa3bc31.pdf

21小时前

Book学术机器人

2026/3/14 21:47:57 未找到该文献，机器人已退出，请等待人工下载

2026/3/14 21:47:57 Book学术AI机器人收到请求，开始寻找文献

2026/3/14 21:47:57 已向机器人发送请求

21小时前

王睿童发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierToxin-responsive Litsea cubeba essential oil liposomes for enhancing beef safety by inhibiting Clostridium perfringens and its exotoxin activity